Stocks / HROW vs USPH

Harrow, Inc. (HROW) vs U.S. Physical Therapy, Inc. (USPH)

Harrow, Inc. and U.S. Physical Therapy, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.

HROW is the larger company ($1.4B vs $0.9B). On the fundamentals, HROW grows revenue faster (41.0% vs 13.0%); USPH earns a higher net margin (5.1% vs -1.9%); USPH has the stronger return on equity (8.3% vs -9.8%). Over the last five years, HROW returned 298.3% vs -40.8%. On the filings, USPH carries fewer potential red flags (0 vs 3). Full numbers below — the stronger figure on each row is in green.

AI verdict — HROW vs USPH, read from the filings

The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.

 Harrow, Inc. (HROW)U.S. Physical Therapy, Inc. (USPH)
Market cap$1.4B$0.9B
Revenue (latest FY)$272.30M$780.99M
Net income (latest FY)$-5.14M$39.58M
Revenue growth (5y CAGR)41.0%13.0%
Net margin-1.9%5.1%
Return on equity-9.8%8.3%
P/E ratio124.5
Dividend yield2.9%
Profitable years (of last 10)210
Positive free cash flowYesYes

Performance — HROW vs USPH

Total returns from monthly split- and dividend-adjusted closes; 52-week range from the latest quote. Past performance is not a prediction.

 Harrow, Inc. (HROW)U.S. Physical Therapy, Inc. (USPH)
1-year return21.2%-18.4%
3-year return94.3%-45.3%
5-year return298.3%-40.8%
10-year return884.0%19.4%
52-week range$28.54–$54.85$58.19–$93.50

Verify the comparison

Use the filing period and source shown by each tool before treating two figures as comparable.

Compare with another company:

See the full HROW vs USPH breakdown

Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.

Open HROW's full financials →   Open USPH's full financials →

More comparisons

Frequently asked questions

Which is bigger, HROW or USPH?

Harrow, Inc. is larger by market capitalization — $1.4B versus $0.9B.

Which grows faster, HROW or USPH?

Over the last five fiscal years, Harrow, Inc. grew revenue faster — 41.0%/yr versus 13.0%/yr, computed from SEC-filed statements.

Where does this data come from?

All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.

Keep exploring

HROW fundamentals → · USPH fundamentals → · All 1,500+ companies → · Free screener →